The efficacy of hyperbaric oxygen therapy in stroke patients:a real-world studyOA
Background:Hyperbaric oxygen therapy(HBOT)is widely used as an adjunctive intervention in stroke reha-bilitation;however,its therapeutic benefit remains uncertain.This study investigated the clinical effectiveness of HBOT in improving recovery among patients with subacute-to-chronic stroke.Methods:A total of 564 patients(14 days to 6 months after stroke onset)treated at Shanghai Yangzhi Rehabil-itation Hospital between January 2017 and December 2024 were enrolled.Patients were assigned to either the HBOT group(n=250),which received 1540 HBOT sessions at 1.8 ATA in addition to routine rehabilitation,or the non-HBOT group(n=314),which received routine rehabilitation alone.Propensity score matching(PSM)and inverse probability weighting(IPW)were used to balance baseline characteristics between groups.The primary outcome was the change in National Institutes of Health Stroke Scale(NIHSS)score from baseline(ΔNIHSS).Secondary outcomes included changes in Functional Test for the Hemiplegic Upper ExtremityHong Kong(FTHUE-HK),Berg Balance Scale(BBS),and Modified Rankin Scale(mRS)scores,expressed asΔFTHUE-HK,ΔBBS,andΔmRS,respectively.Results:After 1:1 PSM,83 matched pairs were included.No significant between-group differences were observed inΔNIHSS,ΔFTHUE-HK,ΔBBS,orΔmRS.Sensitivity analyses confirmed these findings.IPW applied to the original cohort demonstrated a modest but statistically significant reduction in NIHsS score(β=0.3428,p=0.040);however,the observed improvement was well below the established 2-point minimal clinically important difference.Post hoc subgroup analyses suggested that patients who completed 15-24 HBOT sessions experienced greater neurological improvement(interaction p=0.004).Disease duration was not associated with treatment response.Conclusions:HBOT was not associated with clinically meaningful improvements in overall functional recovery among patients with subacute-to-chronic stroke.Although weighted analyses identified a small statistically significant reduction in NIHsS score,the effect was not clinically meaningful.Exploratory subgroup analyses suggested a possible dose-related benefit that warrants confirmation in prospective studies.
Linguo Zhang;Yue Hu;Xiao Han;Li Fan;Hong Zhang;Qiuzhen Zhang;Zhongfei Bai;Lingjing Jin;Danmei Lan
Department of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,ChinaDepartment of Neurology and Neurological Rehabilitation,Shanghai Yangzhi Rehabilitation Hospital(Shanghai Sunshine Rehabilitation Center),School of Medicine,Tongji University,Shanghai 201619,China
医药卫生
Hyperbaric oxygen therapyStrokeRehabilitationRecovery periodNational Institutes of Health Stroke ScaleBerg balance scale
《Journal of Neurorestoratology》 2026 (4)
P.38-46,9
supported by grants from the National Clinical Key Specialty Construction Project of China(Z155080000004)Shanghai Research Center of Rehabilitation Medicine(Top Priority Research Center of Shanghai)(2023ZZ02027)Shanghai Clinical Research Ward(SHDC2023CRW018B)Shanghai Hospital Development Center Foun-dation-Shanghai Municipal Hospital Rehabilitation Medicine Specialty Alliance(SHDC22023304)Shanghai Disabled Persons''Federation Key Laboratory of Intelligent Rehabilitation Assistive Appliance and Technology.
评论